• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . Gastrointestinal Bleeding in Patients with SARS-CoV-2 Infection Managed by Interventional Radiology

tetano

Editor, Senior Moderator
J Clin Med


. 2021 Oct 17;10(20):4758.
doi: 10.3390/jcm10204758.
Gastrointestinal Bleeding in Patients with SARS-CoV-2 Infection Managed by Interventional Radiology


Anna Maria Ierardi[SUP] 1 [/SUP], Andrea Coppola[SUP] 2 [/SUP], Silvia Tortora[SUP] 3 [/SUP], Elena Valconi[SUP] 3 [/SUP], Filippo Piacentino[SUP] 2 [/SUP], Federico Fontana[SUP] 2 [/SUP], Elvira Stellato[SUP] 3 [/SUP], Chiara Beatrice Cogliati[SUP] 4 [/SUP], Daniela Torzillo[SUP] 4 [/SUP], Emanuela Giampalma[SUP] 5 [/SUP], Matteo Renzulli[SUP] 6 [/SUP], Irene Bargellini[SUP] 7 [/SUP], Roberto Cioni[SUP] 7 [/SUP], Rossella Scandiffio[SUP] 7 [/SUP], Angelo Spinazzola[SUP] 8 [/SUP], Riccardo Alessandro Foà[SUP] 8 [/SUP], Costantino Del Giudice[SUP] 9 [/SUP], Massimo Venturini[SUP] 2 [/SUP], Gianpaolo Carrafiello[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

Background: This study was conducted to evaluate the technical and clinical success of trans-arterial embolization (TAE) as a treatment of gastrointestinal bleeding (GIB) in Coronavirus Disease 2019 (COVID-19) patients and to describe its safety; moreover, we describe the characteristics of these patients.
Methods: Thirty-four COVID-19 hospitalized patients presented with GIB. Risk factors, drugs administered for COVID-19 infection, and clinical and biological parameters were evaluated. Furthermore, intraprocedural data and outcomes of embolization were analyzed.
Results: GIB was more frequent in male. Overweight, hypertension, diabetes, previous cardiac disease, and anticoagulation preadmission (48.5%) were frequently found in our population. Previous or actual COVID Acute respiratory distress syndrome (ARDS) and a high level of D-dimer were encountered in most cases. Upper GIB was more frequent than lower GIB. Technical and clinical success rates of embolization were 88.2% and 94.1%, respectively. The complication rate was 5.9%.
Conclusions: Our study highlights the most frequent characteristics of COVID-19 patients with GIB. Embolization is feasible, effective, and safe.

Keywords: COVID-19; GIB; embolization; gastrointestinal bleeding; interventional radiology; risk factors.
 
Back
Top Bottom